The Psychedelics Newsletter, Issue 142
HOW PSYCHEDELICS COULD HELP THOSE LIVING WITH ALCOHOL USE DISORDERS
Alcohol use disorders (AUD) are estimated to affect around 237 million people across the globe, with 3 million deaths each year attributed to the harmful use of alcohol.
Despite this prevalence, there is a lack of effective treatment options and relapse rates remain high, but hope is on the horizon in the form of clinical research that is starting to show the therapeutic potential of psychedelic compounds for problematic drinking.
AUD affects millions of people around the world. In fact, approximately one in every 20 deaths globally are in some way related to alcohol, be it through disease, injury, or accident. There are over 600,000 dependent drinkers in England alone, and, in the US, roughly a third of people meet the criteria for AUD on a lifetime basis. Sadly though, only 21.9% of patients across the globe receive treatment for AUD and many struggle with relapse.
PSILOCYBIN THERAPY FOR ANOREXIA NERVOSA
Eating disorders have increased 140% over the last decade, but current treatment options are often ineffective.
OREGON'S LUCRATIVE PSYCHEDELIC INDUSTRY
The state’s first psilocybin provider to announce its pricing said a single high-dose trip will cost US$3,500.
领英推荐
BUSINESS AND INVESTMENT
Would your organisation benefit from engaging with Europe's psychedelic medicine community?
Partnership with PSYCH provides the opportunity to engage an audience ready to support the development of psychedelic healthcare.
Previous partners include COMPASS Pathways, Beckley Psytech and Awakn Life Sciences.?
For more information and to request the PSYCH media kit, please email?[email protected]
SCIENCE AND RESEARCH
REGULATION AND LEGISLATION
ARTICLES OF INTEREST